News
Conshohocken, Pennsylvania Thursday, August 21, 2025, 14:00 Hrs [IST] ...
On Friday, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Wegovy for the treatment of ...
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...
1h
MyChesCo on MSNMadrigal Pharmaceuticals Secures EU Approval for First-Ever MASH Therapy
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced that the European Commission (EC) has granted conditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results